Published in Cancer Weekly, May 27th, 1996
Research results were reported in the May 15, 1996, issue of Cancer.
Dr. Marcello Tavio, of the Italian Cooperative Study Group on AIDS and Tumors, (GICAT) and colleagues evaluated the responses of 38 patients with progressive, extensive HIV related KS after treatment with doxorubicin, bleomycin and vindesine (ABVi).
"Vindesine was used instead of vincristine because of its lower neurotoxicity," Tavio explained.
Of the 21 patients who responded to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1996-05-27)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.